Testing effectiveness (Phase 2)Study completedNCT01186068
What this trial is testing
Dose Response Study of Patients With Erythematous Rosacea
Who this might be right for
Erythematous (Type One) Rosacea
Vicept Therapeutics, Inc. 175
Showing 5 of 5 results